Global Pharmaceutical Development Preclinical CRO Supply, Demand and Key Producers, 2024-2030

Description

The global Pharmaceutical Development Preclinical CRO market size is expected to reach $ 19910 million by 2030, rising at a market growth of 7.7% CAGR during the forecast period (2024-2030).

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

A preclinical CRO (contract research organizations) helps new medical product developers (including devices, drugs, biologics and more) prove those products are safe and effective in live models the FDA deems approximate as closely as possible the human anatomy prior to those devices enter clinical trials (or receiving other approvals like 510Ks) or use for human care. Pharmaceutical companies invest lots of money to research and produce drugs/medicines for patients. Patients and healthcare providers (doctors, nurses, hospitals, nursing homes, clinics, etc.) are all dependent on these companies for the treatment of diseases.

This report studies the global Pharmaceutical Development Preclinical CRO demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Pharmaceutical Development Preclinical CRO, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Pharmaceutical Development Preclinical CRO that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Pharmaceutical Development Preclinical CRO total market, 2019-2030, (USD Million)
Global Pharmaceutical Development Preclinical CRO total market by region & country, CAGR, 2019-2030, (USD Million)
U.S. VS China: Pharmaceutical Development Preclinical CRO total market, key domestic companies and share, (USD Million)
Global Pharmaceutical Development Preclinical CRO revenue by player and market share 2019-2024, (USD Million)
Global Pharmaceutical Development Preclinical CRO total market by Type, CAGR, 2019-2030, (USD Million)
Global Pharmaceutical Development Preclinical CRO total market by Application, CAGR, 2019-2030, (USD Million).

This reports profiles major players in the global Pharmaceutical Development Preclinical CRO market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Charles River, Wuxi AppTec, Labcorp, Eurofins Scientific, PPD, Inc., ICON Plc., Pharmaron, Inotiv and ChemPartner, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Pharmaceutical Development Preclinical CRO market.

Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.

Global Pharmaceutical Development Preclinical CRO Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World

Global Pharmaceutical Development Preclinical CRO Market, Segmentation by Type
    Bioanalysis and DMPK Studies
    Toxicology Testing
    Safety Pharmacology
    Others

Global Pharmaceutical Development Preclinical CRO Market, Segmentation by Application
    Small and Medium Pharmaceutical Company
    Large Pharmaceutical Company

Companies Profiled:
    Charles River
    Wuxi AppTec
    Labcorp
    Eurofins Scientific
    PPD, Inc.
    ICON Plc.
    Pharmaron
    Inotiv
    ChemPartner
    JOINN Lab
    EVOTEC
    Medicilon
    Crown Bioscience
    Champion Oncology

Key Questions Answered
1. How big is the global Pharmaceutical Development Preclinical CRO market?
2. What is the demand of the global Pharmaceutical Development Preclinical CRO market?
3. What is the year over year growth of the global Pharmaceutical Development Preclinical CRO market?
4. What is the total value of the global Pharmaceutical Development Preclinical CRO market?
5. Who are the major players in the global Pharmaceutical Development Preclinical CRO market?

Table of Contents

1 Supply Summary
    1.1 Pharmaceutical Development Preclinical CRO Introduction
    1.2 World Pharmaceutical Development Preclinical CRO Market Size & Forecast (2019 & 2023 & 2030)
    1.3 World Pharmaceutical Development Preclinical CRO Total Market by Region (by Headquarter Location)
        1.3.1 World Pharmaceutical Development Preclinical CRO Market Size by Region (2019-2030), (by Headquarter Location)
        1.3.2 United States Pharmaceutical Development Preclinical CRO Market Size (2019-2030)
        1.3.3 China Pharmaceutical Development Preclinical CRO Market Size (2019-2030)
        1.3.4 Europe Pharmaceutical Development Preclinical CRO Market Size (2019-2030)
        1.3.5 Japan Pharmaceutical Development Preclinical CRO Market Size (2019-2030)
        1.3.6 South Korea Pharmaceutical Development Preclinical CRO Market Size (2019-2030)
        1.3.7 ASEAN Pharmaceutical Development Preclinical CRO Market Size (2019-2030)
        1.3.8 India Pharmaceutical Development Preclinical CRO Market Size (2019-2030)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Pharmaceutical Development Preclinical CRO Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Pharmaceutical Development Preclinical CRO Major Market Trends

2 Demand Summary
    2.1 World Pharmaceutical Development Preclinical CRO Consumption Value (2019-2030)
    2.2 World Pharmaceutical Development Preclinical CRO Consumption Value by Region
        2.2.1 World Pharmaceutical Development Preclinical CRO Consumption Value by Region (2019-2024)
        2.2.2 World Pharmaceutical Development Preclinical CRO Consumption Value Forecast by Region (2025-2030)
    2.3 United States Pharmaceutical Development Preclinical CRO Consumption Value (2019-2030)
    2.4 China Pharmaceutical Development Preclinical CRO Consumption Value (2019-2030)
    2.5 Europe Pharmaceutical Development Preclinical CRO Consumption Value (2019-2030)
    2.6 Japan Pharmaceutical Development Preclinical CRO Consumption Value (2019-2030)
    2.7 South Korea Pharmaceutical Development Preclinical CRO Consumption Value (2019-2030)
    2.8 ASEAN Pharmaceutical Development Preclinical CRO Consumption Value (2019-2030)
    2.9 India Pharmaceutical Development Preclinical CRO Consumption Value (2019-2030)

3 World Pharmaceutical Development Preclinical CRO Companies Competitive Analysis
    3.1 World Pharmaceutical Development Preclinical CRO Revenue by Player (2019-2024)
    3.2 Industry Rank and Concentration Rate (CR)
        3.2.1 Global Pharmaceutical Development Preclinical CRO Industry Rank of Major Players
        3.2.2 Global Concentration Ratios (CR4) for Pharmaceutical Development Preclinical CRO in 2023
        3.2.3 Global Concentration Ratios (CR8) for Pharmaceutical Development Preclinical CRO in 2023
    3.3 Pharmaceutical Development Preclinical CRO Company Evaluation Quadrant
    3.4 Pharmaceutical Development Preclinical CRO Market: Overall Company Footprint Analysis
        3.4.1 Pharmaceutical Development Preclinical CRO Market: Region Footprint
        3.4.2 Pharmaceutical Development Preclinical CRO Market: Company Product Type Footprint
        3.4.3 Pharmaceutical Development Preclinical CRO Market: Company Product Application Footprint
    3.5 Competitive Environment
        3.5.1 Historical Structure of the Industry
        3.5.2 Barriers of Market Entry
        3.5.3 Factors of Competition
    3.6 Mergers, Acquisitions Activity

4 United States VS China VS Rest of the World (by Headquarter Location)
    4.1 United States VS China: Pharmaceutical Development Preclinical CRO Revenue Comparison (by Headquarter Location)
        4.1.1 United States VS China: Pharmaceutical Development Preclinical CRO Market Size Comparison (2019 & 2023 & 2030) (by Headquarter Location)
        4.1.2 United States VS China: Pharmaceutical Development Preclinical CRO Revenue Market Share Comparison (2019 & 2023 & 2030)
    4.2 United States Based Companies VS China Based Companies: Pharmaceutical Development Preclinical CRO Consumption Value Comparison
        4.2.1 United States VS China: Pharmaceutical Development Preclinical CRO Consumption Value Comparison (2019 & 2023 & 2030)
        4.2.2 United States VS China: Pharmaceutical Development Preclinical CRO Consumption Value Market Share Comparison (2019 & 2023 & 2030)
    4.3 United States Based Pharmaceutical Development Preclinical CRO Companies and Market Share, 2019-2024
        4.3.1 United States Based Pharmaceutical Development Preclinical CRO Companies, Headquarters (States, Country)
        4.3.2 United States Based Companies Pharmaceutical Development Preclinical CRO Revenue, (2019-2024)
    4.4 China Based Companies Pharmaceutical Development Preclinical CRO Revenue and Market Share, 2019-2024
        4.4.1 China Based Pharmaceutical Development Preclinical CRO Companies, Company Headquarters (Province, Country)
        4.4.2 China Based Companies Pharmaceutical Development Preclinical CRO Revenue, (2019-2024)
    4.5 Rest of World Based Pharmaceutical Development Preclinical CRO Companies and Market Share, 2019-2024
        4.5.1 Rest of World Based Pharmaceutical Development Preclinical CRO Companies, Headquarters (States, Country)
        4.5.2 Rest of World Based Companies Pharmaceutical Development Preclinical CRO Revenue, (2019-2024)

5 Market Analysis by Type
    5.1 World Pharmaceutical Development Preclinical CRO Market Size Overview by Type: 2019 VS 2023 VS 2030
    5.2 Segment Introduction by Type
        5.2.1 Bioanalysis and DMPK Studies
        5.2.2 Toxicology Testing
        5.2.3 Safety Pharmacology
        5.2.4 Others
    5.3 Market Segment by Type
        5.3.1 World Pharmaceutical Development Preclinical CRO Market Size by Type (2019-2024)
        5.3.2 World Pharmaceutical Development Preclinical CRO Market Size by Type (2025-2030)
        5.3.3 World Pharmaceutical Development Preclinical CRO Market Size Market Share by Type (2019-2030)

6 Market Analysis by Application
    6.1 World Pharmaceutical Development Preclinical CRO Market Size Overview by Application: 2019 VS 2023 VS 2030
    6.2 Segment Introduction by Application
        6.2.1 Small and Medium Pharmaceutical Company
        6.2.2 Large Pharmaceutical Company
    6.3 Market Segment by Application
        6.3.1 World Pharmaceutical Development Preclinical CRO Market Size by Application (2019-2024)
        6.3.2 World Pharmaceutical Development Preclinical CRO Market Size by Application (2025-2030)
        6.3.3 World Pharmaceutical Development Preclinical CRO Market Size by Application (2019-2030)

7 Company Profiles
    7.1 Charles River
        7.1.1 Charles River Details
        7.1.2 Charles River Major Business
        7.1.3 Charles River Pharmaceutical Development Preclinical CRO Product and Services
        7.1.4 Charles River Pharmaceutical Development Preclinical CRO Revenue, Gross Margin and Market Share (2019-2024)
        7.1.5 Charles River Recent Developments/Updates
        7.1.6 Charles River Competitive Strengths & Weaknesses
    7.2 Wuxi AppTec
        7.2.1 Wuxi AppTec Details
        7.2.2 Wuxi AppTec Major Business
        7.2.3 Wuxi AppTec Pharmaceutical Development Preclinical CRO Product and Services
        7.2.4 Wuxi AppTec Pharmaceutical Development Preclinical CRO Revenue, Gross Margin and Market Share (2019-2024)
        7.2.5 Wuxi AppTec Recent Developments/Updates
        7.2.6 Wuxi AppTec Competitive Strengths & Weaknesses
    7.3 Labcorp
        7.3.1 Labcorp Details
        7.3.2 Labcorp Major Business
        7.3.3 Labcorp Pharmaceutical Development Preclinical CRO Product and Services
        7.3.4 Labcorp Pharmaceutical Development Preclinical CRO Revenue, Gross Margin and Market Share (2019-2024)
        7.3.5 Labcorp Recent Developments/Updates
        7.3.6 Labcorp Competitive Strengths & Weaknesses
    7.4 Eurofins Scientific
        7.4.1 Eurofins Scientific Details
        7.4.2 Eurofins Scientific Major Business
        7.4.3 Eurofins Scientific Pharmaceutical Development Preclinical CRO Product and Services
        7.4.4 Eurofins Scientific Pharmaceutical Development Preclinical CRO Revenue, Gross Margin and Market Share (2019-2024)
        7.4.5 Eurofins Scientific Recent Developments/Updates
        7.4.6 Eurofins Scientific Competitive Strengths & Weaknesses
    7.5 PPD, Inc.
        7.5.1 PPD, Inc. Details
        7.5.2 PPD, Inc. Major Business
        7.5.3 PPD, Inc. Pharmaceutical Development Preclinical CRO Product and Services
        7.5.4 PPD, Inc. Pharmaceutical Development Preclinical CRO Revenue, Gross Margin and Market Share (2019-2024)
        7.5.5 PPD, Inc. Recent Developments/Updates
        7.5.6 PPD, Inc. Competitive Strengths & Weaknesses
    7.6 ICON Plc.
        7.6.1 ICON Plc. Details
        7.6.2 ICON Plc. Major Business
        7.6.3 ICON Plc. Pharmaceutical Development Preclinical CRO Product and Services
        7.6.4 ICON Plc. Pharmaceutical Development Preclinical CRO Revenue, Gross Margin and Market Share (2019-2024)
        7.6.5 ICON Plc. Recent Developments/Updates
        7.6.6 ICON Plc. Competitive Strengths & Weaknesses
    7.7 Pharmaron
        7.7.1 Pharmaron Details
        7.7.2 Pharmaron Major Business
        7.7.3 Pharmaron Pharmaceutical Development Preclinical CRO Product and Services
        7.7.4 Pharmaron Pharmaceutical Development Preclinical CRO Revenue, Gross Margin and Market Share (2019-2024)
        7.7.5 Pharmaron Recent Developments/Updates
        7.7.6 Pharmaron Competitive Strengths & Weaknesses
    7.8 Inotiv
        7.8.1 Inotiv Details
        7.8.2 Inotiv Major Business
        7.8.3 Inotiv Pharmaceutical Development Preclinical CRO Product and Services
        7.8.4 Inotiv Pharmaceutical Development Preclinical CRO Revenue, Gross Margin and Market Share (2019-2024)
        7.8.5 Inotiv Recent Developments/Updates
        7.8.6 Inotiv Competitive Strengths & Weaknesses
    7.9 ChemPartner
        7.9.1 ChemPartner Details
        7.9.2 ChemPartner Major Business
        7.9.3 ChemPartner Pharmaceutical Development Preclinical CRO Product and Services
        7.9.4 ChemPartner Pharmaceutical Development Preclinical CRO Revenue, Gross Margin and Market Share (2019-2024)
        7.9.5 ChemPartner Recent Developments/Updates
        7.9.6 ChemPartner Competitive Strengths & Weaknesses
    7.10 JOINN Lab
        7.10.1 JOINN Lab Details
        7.10.2 JOINN Lab Major Business
        7.10.3 JOINN Lab Pharmaceutical Development Preclinical CRO Product and Services
        7.10.4 JOINN Lab Pharmaceutical Development Preclinical CRO Revenue, Gross Margin and Market Share (2019-2024)
        7.10.5 JOINN Lab Recent Developments/Updates
        7.10.6 JOINN Lab Competitive Strengths & Weaknesses
    7.11 EVOTEC
        7.11.1 EVOTEC Details
        7.11.2 EVOTEC Major Business
        7.11.3 EVOTEC Pharmaceutical Development Preclinical CRO Product and Services
        7.11.4 EVOTEC Pharmaceutical Development Preclinical CRO Revenue, Gross Margin and Market Share (2019-2024)
        7.11.5 EVOTEC Recent Developments/Updates
        7.11.6 EVOTEC Competitive Strengths & Weaknesses
    7.12 Medicilon
        7.12.1 Medicilon Details
        7.12.2 Medicilon Major Business
        7.12.3 Medicilon Pharmaceutical Development Preclinical CRO Product and Services
        7.12.4 Medicilon Pharmaceutical Development Preclinical CRO Revenue, Gross Margin and Market Share (2019-2024)
        7.12.5 Medicilon Recent Developments/Updates
        7.12.6 Medicilon Competitive Strengths & Weaknesses
    7.13 Crown Bioscience
        7.13.1 Crown Bioscience Details
        7.13.2 Crown Bioscience Major Business
        7.13.3 Crown Bioscience Pharmaceutical Development Preclinical CRO Product and Services
        7.13.4 Crown Bioscience Pharmaceutical Development Preclinical CRO Revenue, Gross Margin and Market Share (2019-2024)
        7.13.5 Crown Bioscience Recent Developments/Updates
        7.13.6 Crown Bioscience Competitive Strengths & Weaknesses
    7.14 Champion Oncology
        7.14.1 Champion Oncology Details
        7.14.2 Champion Oncology Major Business
        7.14.3 Champion Oncology Pharmaceutical Development Preclinical CRO Product and Services
        7.14.4 Champion Oncology Pharmaceutical Development Preclinical CRO Revenue, Gross Margin and Market Share (2019-2024)
        7.14.5 Champion Oncology Recent Developments/Updates
        7.14.6 Champion Oncology Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Pharmaceutical Development Preclinical CRO Industry Chain
    8.2 Pharmaceutical Development Preclinical CRO Upstream Analysis
    8.3 Pharmaceutical Development Preclinical CRO Midstream Analysis
    8.4 Pharmaceutical Development Preclinical CRO Downstream Analysis

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. World Pharmaceutical Development Preclinical CRO Revenue by Region (2019, 2023 and 2030) & (USD Million), (by Headquarter Location)
    Table 2. World Pharmaceutical Development Preclinical CRO Revenue by Region (2019-2024) & (USD Million), (by Headquarter Location)
    Table 3. World Pharmaceutical Development Preclinical CRO Revenue by Region (2025-2030) & (USD Million), (by Headquarter Location)
    Table 4. World Pharmaceutical Development Preclinical CRO Revenue Market Share by Region (2019-2024), (by Headquarter Location)
    Table 5. World Pharmaceutical Development Preclinical CRO Revenue Market Share by Region (2025-2030), (by Headquarter Location)
    Table 6. Major Market Trends
    Table 7. World Pharmaceutical Development Preclinical CRO Consumption Value Growth Rate Forecast by Region (2019 & 2023 & 2030) & (USD Million)
    Table 8. World Pharmaceutical Development Preclinical CRO Consumption Value by Region (2019-2024) & (USD Million)
    Table 9. World Pharmaceutical Development Preclinical CRO Consumption Value Forecast by Region (2025-2030) & (USD Million)
    Table 10. World Pharmaceutical Development Preclinical CRO Revenue by Player (2019-2024) & (USD Million)
    Table 11. Revenue Market Share of Key Pharmaceutical Development Preclinical CRO Players in 2023
    Table 12. World Pharmaceutical Development Preclinical CRO Industry Rank of Major Player, Based on Revenue in 2023
    Table 13. Global Pharmaceutical Development Preclinical CRO Company Evaluation Quadrant
    Table 14. Head Office of Key Pharmaceutical Development Preclinical CRO Player
    Table 15. Pharmaceutical Development Preclinical CRO Market: Company Product Type Footprint
    Table 16. Pharmaceutical Development Preclinical CRO Market: Company Product Application Footprint
    Table 17. Pharmaceutical Development Preclinical CRO Mergers & Acquisitions Activity
    Table 18. United States VS China Pharmaceutical Development Preclinical CRO Market Size Comparison, (2019 & 2023 & 2030) & (USD Million)
    Table 19. United States VS China Pharmaceutical Development Preclinical CRO Consumption Value Comparison, (2019 & 2023 & 2030) & (USD Million)
    Table 20. United States Based Pharmaceutical Development Preclinical CRO Companies, Headquarters (States, Country)
    Table 21. United States Based Companies Pharmaceutical Development Preclinical CRO Revenue, (2019-2024) & (USD Million)
    Table 22. United States Based Companies Pharmaceutical Development Preclinical CRO Revenue Market Share (2019-2024)
    Table 23. China Based Pharmaceutical Development Preclinical CRO Companies, Headquarters (Province, Country)
    Table 24. China Based Companies Pharmaceutical Development Preclinical CRO Revenue, (2019-2024) & (USD Million)
    Table 25. China Based Companies Pharmaceutical Development Preclinical CRO Revenue Market Share (2019-2024)
    Table 26. Rest of World Based Pharmaceutical Development Preclinical CRO Companies, Headquarters (States, Country)
    Table 27. Rest of World Based Companies Pharmaceutical Development Preclinical CRO Revenue, (2019-2024) & (USD Million)
    Table 28. Rest of World Based Companies Pharmaceutical Development Preclinical CRO Revenue Market Share (2019-2024)
    Table 29. World Pharmaceutical Development Preclinical CRO Market Size by Type, (USD Million), 2019 & 2023 & 2030
    Table 30. World Pharmaceutical Development Preclinical CRO Market Size by Type (2019-2024) & (USD Million)
    Table 31. World Pharmaceutical Development Preclinical CRO Market Size by Type (2025-2030) & (USD Million)
    Table 32. World Pharmaceutical Development Preclinical CRO Market Size by Application, (USD Million), 2019 & 2023 & 2030
    Table 33. World Pharmaceutical Development Preclinical CRO Market Size by Application (2019-2024) & (USD Million)
    Table 34. World Pharmaceutical Development Preclinical CRO Market Size by Application (2025-2030) & (USD Million)
    Table 35. Charles River Basic Information, Area Served and Competitors
    Table 36. Charles River Major Business
    Table 37. Charles River Pharmaceutical Development Preclinical CRO Product and Services
    Table 38. Charles River Pharmaceutical Development Preclinical CRO Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 39. Charles River Recent Developments/Updates
    Table 40. Charles River Competitive Strengths & Weaknesses
    Table 41. Wuxi AppTec Basic Information, Area Served and Competitors
    Table 42. Wuxi AppTec Major Business
    Table 43. Wuxi AppTec Pharmaceutical Development Preclinical CRO Product and Services
    Table 44. Wuxi AppTec Pharmaceutical Development Preclinical CRO Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 45. Wuxi AppTec Recent Developments/Updates
    Table 46. Wuxi AppTec Competitive Strengths & Weaknesses
    Table 47. Labcorp Basic Information, Area Served and Competitors
    Table 48. Labcorp Major Business
    Table 49. Labcorp Pharmaceutical Development Preclinical CRO Product and Services
    Table 50. Labcorp Pharmaceutical Development Preclinical CRO Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 51. Labcorp Recent Developments/Updates
    Table 52. Labcorp Competitive Strengths & Weaknesses
    Table 53. Eurofins Scientific Basic Information, Area Served and Competitors
    Table 54. Eurofins Scientific Major Business
    Table 55. Eurofins Scientific Pharmaceutical Development Preclinical CRO Product and Services
    Table 56. Eurofins Scientific Pharmaceutical Development Preclinical CRO Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 57. Eurofins Scientific Recent Developments/Updates
    Table 58. Eurofins Scientific Competitive Strengths & Weaknesses
    Table 59. PPD, Inc. Basic Information, Area Served and Competitors
    Table 60. PPD, Inc. Major Business
    Table 61. PPD, Inc. Pharmaceutical Development Preclinical CRO Product and Services
    Table 62. PPD, Inc. Pharmaceutical Development Preclinical CRO Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 63. PPD, Inc. Recent Developments/Updates
    Table 64. PPD, Inc. Competitive Strengths & Weaknesses
    Table 65. ICON Plc. Basic Information, Area Served and Competitors
    Table 66. ICON Plc. Major Business
    Table 67. ICON Plc. Pharmaceutical Development Preclinical CRO Product and Services
    Table 68. ICON Plc. Pharmaceutical Development Preclinical CRO Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 69. ICON Plc. Recent Developments/Updates
    Table 70. ICON Plc. Competitive Strengths & Weaknesses
    Table 71. Pharmaron Basic Information, Area Served and Competitors
    Table 72. Pharmaron Major Business
    Table 73. Pharmaron Pharmaceutical Development Preclinical CRO Product and Services
    Table 74. Pharmaron Pharmaceutical Development Preclinical CRO Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 75. Pharmaron Recent Developments/Updates
    Table 76. Pharmaron Competitive Strengths & Weaknesses
    Table 77. Inotiv Basic Information, Area Served and Competitors
    Table 78. Inotiv Major Business
    Table 79. Inotiv Pharmaceutical Development Preclinical CRO Product and Services
    Table 80. Inotiv Pharmaceutical Development Preclinical CRO Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 81. Inotiv Recent Developments/Updates
    Table 82. Inotiv Competitive Strengths & Weaknesses
    Table 83. ChemPartner Basic Information, Area Served and Competitors
    Table 84. ChemPartner Major Business
    Table 85. ChemPartner Pharmaceutical Development Preclinical CRO Product and Services
    Table 86. ChemPartner Pharmaceutical Development Preclinical CRO Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 87. ChemPartner Recent Developments/Updates
    Table 88. ChemPartner Competitive Strengths & Weaknesses
    Table 89. JOINN Lab Basic Information, Area Served and Competitors
    Table 90. JOINN Lab Major Business
    Table 91. JOINN Lab Pharmaceutical Development Preclinical CRO Product and Services
    Table 92. JOINN Lab Pharmaceutical Development Preclinical CRO Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 93. JOINN Lab Recent Developments/Updates
    Table 94. JOINN Lab Competitive Strengths & Weaknesses
    Table 95. EVOTEC Basic Information, Area Served and Competitors
    Table 96. EVOTEC Major Business
    Table 97. EVOTEC Pharmaceutical Development Preclinical CRO Product and Services
    Table 98. EVOTEC Pharmaceutical Development Preclinical CRO Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 99. EVOTEC Recent Developments/Updates
    Table 100. EVOTEC Competitive Strengths & Weaknesses
    Table 101. Medicilon Basic Information, Area Served and Competitors
    Table 102. Medicilon Major Business
    Table 103. Medicilon Pharmaceutical Development Preclinical CRO Product and Services
    Table 104. Medicilon Pharmaceutical Development Preclinical CRO Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 105. Medicilon Recent Developments/Updates
    Table 106. Medicilon Competitive Strengths & Weaknesses
    Table 107. Crown Bioscience Basic Information, Area Served and Competitors
    Table 108. Crown Bioscience Major Business
    Table 109. Crown Bioscience Pharmaceutical Development Preclinical CRO Product and Services
    Table 110. Crown Bioscience Pharmaceutical Development Preclinical CRO Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 111. Crown Bioscience Recent Developments/Updates
    Table 112. Champion Oncology Basic Information, Area Served and Competitors
    Table 113. Champion Oncology Major Business
    Table 114. Champion Oncology Pharmaceutical Development Preclinical CRO Product and Services
    Table 115. Champion Oncology Pharmaceutical Development Preclinical CRO Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 116. Global Key Players of Pharmaceutical Development Preclinical CRO Upstream (Raw Materials)
    Table 117. Pharmaceutical Development Preclinical CRO Typical Customers
List of Figure
    Figure 1. Pharmaceutical Development Preclinical CRO Picture
    Figure 2. World Pharmaceutical Development Preclinical CRO Total Market Size: 2019 & 2023 & 2030, (USD Million)
    Figure 3. World Pharmaceutical Development Preclinical CRO Total Market Size (2019-2030) & (USD Million)
    Figure 4. World Pharmaceutical Development Preclinical CRO Revenue Market Share by Region (2019, 2023 and 2030) & (USD Million) , (by Headquarter Location)
    Figure 5. World Pharmaceutical Development Preclinical CRO Revenue Market Share by Region (2019-2030), (by Headquarter Location)
    Figure 6. United States Based Company Pharmaceutical Development Preclinical CRO Revenue (2019-2030) & (USD Million)
    Figure 7. China Based Company Pharmaceutical Development Preclinical CRO Revenue (2019-2030) & (USD Million)
    Figure 8. Europe Based Company Pharmaceutical Development Preclinical CRO Revenue (2019-2030) & (USD Million)
    Figure 9. Japan Based Company Pharmaceutical Development Preclinical CRO Revenue (2019-2030) & (USD Million)
    Figure 10. South Korea Based Company Pharmaceutical Development Preclinical CRO Revenue (2019-2030) & (USD Million)
    Figure 11. ASEAN Based Company Pharmaceutical Development Preclinical CRO Revenue (2019-2030) & (USD Million)
    Figure 12. India Based Company Pharmaceutical Development Preclinical CRO Revenue (2019-2030) & (USD Million)
    Figure 13. Pharmaceutical Development Preclinical CRO Market Drivers
    Figure 14. Factors Affecting Demand
    Figure 15. World Pharmaceutical Development Preclinical CRO Consumption Value (2019-2030) & (USD Million)
    Figure 16. World Pharmaceutical Development Preclinical CRO Consumption Value Market Share by Region (2019-2030)
    Figure 17. United States Pharmaceutical Development Preclinical CRO Consumption Value (2019-2030) & (USD Million)
    Figure 18. China Pharmaceutical Development Preclinical CRO Consumption Value (2019-2030) & (USD Million)
    Figure 19. Europe Pharmaceutical Development Preclinical CRO Consumption Value (2019-2030) & (USD Million)
    Figure 20. Japan Pharmaceutical Development Preclinical CRO Consumption Value (2019-2030) & (USD Million)
    Figure 21. South Korea Pharmaceutical Development Preclinical CRO Consumption Value (2019-2030) & (USD Million)
    Figure 22. ASEAN Pharmaceutical Development Preclinical CRO Consumption Value (2019-2030) & (USD Million)
    Figure 23. India Pharmaceutical Development Preclinical CRO Consumption Value (2019-2030) & (USD Million)
    Figure 24. Producer Shipments of Pharmaceutical Development Preclinical CRO by Player Revenue ($MM) and Market Share (%): 2023
    Figure 25. Global Four-firm Concentration Ratios (CR4) for Pharmaceutical Development Preclinical CRO Markets in 2023
    Figure 26. Global Four-firm Concentration Ratios (CR8) for Pharmaceutical Development Preclinical CRO Markets in 2023
    Figure 27. United States VS China: Pharmaceutical Development Preclinical CRO Revenue Market Share Comparison (2019 & 2023 & 2030)
    Figure 28. United States VS China: Pharmaceutical Development Preclinical CRO Consumption Value Market Share Comparison (2019 & 2023 & 2030)
    Figure 29. World Pharmaceutical Development Preclinical CRO Market Size by Type, (USD Million), 2019 & 2023 & 2030
    Figure 30. World Pharmaceutical Development Preclinical CRO Market Size Market Share by Type in 2023
    Figure 31. Bioanalysis and DMPK Studies
    Figure 32. Toxicology Testing
    Figure 33. Safety Pharmacology
    Figure 34. Others
    Figure 35. World Pharmaceutical Development Preclinical CRO Market Size Market Share by Type (2019-2030)
    Figure 36. World Pharmaceutical Development Preclinical CRO Market Size by Application, (USD Million), 2019 & 2023 & 2030
    Figure 37. World Pharmaceutical Development Preclinical CRO Market Size Market Share by Application in 2023
    Figure 38. Small and Medium Pharmaceutical Company
    Figure 39. Large Pharmaceutical Company
    Figure 40. Pharmaceutical Development Preclinical CRO Industrial Chain
    Figure 41. Methodology
    Figure 42. Research Process and Data Source

Companies Mentioned

Charles River
Wuxi AppTec
Labcorp
Eurofins Scientific
PPD, Inc.
ICON Plc.
Pharmaron
Inotiv
ChemPartner
JOINN Lab
EVOTEC
Medicilon
Crown Bioscience
Champion Oncology